Atlas Trials

Restrictive Use of Dexamethasone in Glioblastoma

Clinical trial NCT04266977 · RECRUITING

Trial details

NCT number
NCT04266977
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
GlioblastomaDexamethasoneSteroids
Start date
2020-05-08
Primary completion
2027-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.